Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





Income Statement
Balance Sheet
Cash Flow Statement
Segments

Common Size IS
Op Efficiency
Credit Analysis

Immunovant, Inc. (IMVT)

Cash Flow Statement

Standardized | As Reported Annual | Quarterly | TTM
  Older >>
In millions, except per share itemsJun-30-23Dec-31-22Jun-30-22Mar-31-22Dec-31-21Sep-30-21Jun-30-21Mar-31-21
   10-Q10-Q10-Q10-K10-Q10-Q10-Q10-K
Cash flows from operating activities          
Net loss  -73.9-63.2-40.4-47.2-41.4-68.2-30.5-28.2
   
Adjustments to reconcile net loss to net cash used in operating activities:          
    Stock-based compensation  10.7 7.711.910.212.23.95.5
    Depreciation on property and equipment  0.1 0.00.00.00.10.00.0
    Non-cash lease expense  0.3 0.30.30.30.60.30.2
    Changes in operating assets and liabilities:          
        Accounts receivable  -0.1 -0.9-11.6-7.9 -0.2-0.6
        Prepaid expenses and other current assets  8.3 -9.25.90.14.03.2-0.3
        Accounts payable  25.0 -17.514.9-0.41.80.70.3
        Accrued expenses  -17.3 -5.5-6.78.37.91.21.9
        Operating lease liabilities  -0.3 -0.3-1.2-0.7 -0.4-0.8
            Net cash used in operating activities  -47.4-63.2-65.8-33.0-31.9-41.3-21.2-22.5
   
Cash flows from investing activities          
Purchase of property and equipment  0.0 0.0-0.1-0.1-0.10.0-0.1
    Net cash used in investing activities  0.0 0.0-0.1-0.1-0.10.0-0.1
   
Cash flows from financing activities          
Proceeds from stock options exercised  0.9 0.0     
    Net cash provided by financing activities  0.9 0.0  200.10.10.8
Effect of exchange rate changes on cash and cash equivalents  0.0 -0.8 0.0   
    Net change in cash and cash equivalents  -46.6 -66.6 126.9   

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy